Stock Updates

Is this Large Market Cap Stock target price reasonable for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)?

The company in question is, Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) currently with a stock price of 13.88 (-1.63% today). The market cap for Ironwood Pharmaceuticals, Inc. is 2047.78, and is in the sector Healthcare, and Drugs – Generic industry. The target price for Ironwood Pharmaceuticals, Inc. is 15. Currently Ironwood Pharmaceuticals, Inc. is trading with a P/E of *TBA, and a forward P/E of *TBA. Average volume for Ironwood Pharmaceuticals, Inc. is 1190.55 and so far today it is 540488.

Performance in the last year for Ironwood Pharmaceuticals, Inc. has been 30.17%. For EPS growth, Ironwood Pharmaceuticals, Inc. has seen a growth of 27.60%, and is looking to grow in the next year to 40.00%. More long term stats show that EPS growth has been -9.80% over the last five years and could be 39.00% for the next five years. Ironwood Pharmaceuticals, Inc. has seen sales growth quarter over quarter at 96.40%, with EPS growth quarter over quarter at 55.60%. The 20-day simple moving average is -3.48%, with the 200-day simple moving average coming to 15.53%.

Since the IPO date for Ironwood Pharmaceuticals, Inc. on the 02/03/2010, Ironwood Pharmaceuticals, Inc. has seen performance year to date to be 21.74%. With Ironwood Pharmaceuticals, Inc. trading at 13.88, the dividend yield is *TBA, and the EPS is -0.67.

So could Ironwood Pharmaceuticals, Inc., be undervalued? Well as said before P/E is *TBA. The PEG is *TBA, P/S is 9.6 and the P/B is at 25.2. The P/cash is 6.3, with P/free cash flow at *TBA.

Ironwood Pharmaceuticals, Inc. ability to deal with debt shows that the current ratio is 4.2, and the quick ratio is *TBA. This is with long term debt/equity at 4.17, and total debt/equity at 4.63.

In terms of margins, Ironwood Pharmaceuticals, Inc. has a gross margin of *TBA, an operating margin of -23.10% and a profit margin of -45.20%.Payout ratio for Ironwood Pharmaceuticals, Inc. is *TBA. Return on assets come to -15.20% with return on investment coming to *TBA.

Insider ownership for Ironwood Pharmaceuticals, Inc., is at 0.50% and institutional ownership comes to *TBA. Outstanding shares are at 145.13. While shares float is 129.29. The float short is currently 10.66%, and short ratio is 11.58.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment